Men diagnosed with both thyroid and prostate cancer actually survive better than those with either cancer alone.
In a SEER database study of 916,151 men, those with both thyroid and prostate cancer had lower all-cause and cancer-specific mortality than men with either cancer alone. TC+PC patients had 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only, and 17% lower all-cause…
Men diagnosed with both thyroid and prostate cancer actually survive better than those with either cancer alone.
In a SEER database study of 916,151 men, those with both thyroid and prostate cancer had lower all-cause and cancer-specific mortality than men with either cancer alone. TC+PC patients had 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only, and 17% lower all-cause mortality and 38% lower PC-specific mortality vs PC-only.
Key Findings
- TC+PC: 22% lower all-cause mortality and 42% lower TC-specific mortality vs TC-only
- TC+PC: 17% lower all-cause mortality and 38% lower PC-specific mortality vs PC-only
- Results confirmed by competing risk models and propensity-score matching
- Analysis drew from 916,151 men in SEER 2000-2021
Implications
Dual cancer history warrants consideration in prognostic evaluation. Mechanisms need investigation.
Caveats
Retrospective SEER database; abstract-only. Causal mechanisms unexplained; healthcare surveillance bias possible.
Source: Medical science monitor : international medical journal of experimental and clinical research — 2026-04-12